Method for treating dystonia with botulinum toxin types C to G
AssigneeAllergan Sales, Inc.
InventorsK. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
Life of this patent
Estimating the term…
Abstract
A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
Claims3
A method for treating tardive dyskinesia, the method comprising the step of administering to a patient suffering from tardive dyskinesia an effective amount of a botulinum toxin selected from a group consisting of the botulinum toxin types C, E, and G, thereby alleviating a symptom of the tardive dyskinesia.
Dependencies are inferred from the claim text.